MALVERN, PA — TELA Bio, Inc. (NASDAQ: TELA) announced that its Board of Directors Compensation Committee approved an inducement grant for Jim Hagen, Senior Vice President – Strategic Commercial Operations. The grant includes an option to purchase 75,000 shares of common stock and restricted stock units covering 30,000 shares, effective June 2, 2025. These equity awards were granted under Nasdaq Rule 5635(c)(4) as part of Mr. Hagen’s employment compensation and to secure his acceptance of the role.
The stock options have an exercise price of $1.42 per share, the closing price of TELA Bio’s common stock on the Grant Date. They have a 10-year term and vest over four years—25% on the first anniversary of the Grant Date, with the remaining 75% vesting monthly over the next three years. The restricted stock units vest annually over four years, contingent on Mr. Hagen’s continued service with TELA Bio.
For the latest news on everything happening in Chester County and the surrounding area, be sure to follow MyChesCo on Google News and MSN.